z-logo
Premium
Carcinoma in situ of the glottic larynx: Excision or irradiation?
Author(s) -
Nguyen Cam,
Naghibzadeh Bizhan,
Black Martin J.,
Rochon Louise,
Shenouda George
Publication year - 1996
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/(sici)1097-0347(199605/06)18:3<225::aid-hed3>3.0.co;2-1
Subject(s) - glottis , medicine , larynx , surgery , radiation therapy , cord , carcinoma
Abstract Background The management of glottic carcinoma in situ (CIS) is controversial, with vocal cord stripping (S) generally accepted as the standard treatment, and radiotherapy (RT) as an alternative. We present our experience with 34 patients treated by either stripping or RT. Methods Between 1974 and 1990, 34 patients with CIS of the glottic larynx were treated at McGill University teaching hospitals. The median age at diagnosis was 67 years, with a male:female ratio of 6:1. All patients had CIS involving the glottis and the pathology was reviewed on all patients. Twenty‐one patients were treated by S and 13 patients by RT as the primary treatment. Results With a median follow‐up of 96 months (25–209 months), the 15‐year actuarial survival rate is 95% for all patients, with 100% and 87% survival rates for S and RT groups, respectively ( p = 0.25). One patient in the RT group developed a subglottic invasive squamous cell carcinoma. On the other hand, 11 patients in the S group developed recurrence and were treated by repeat S (6 patients) or RT (5 patients), with a salvage rate of 100%. Conclusion Although most patients with CIS of the glottis are traditionally treated with vocal cord S, RT is effective in terms of freedom from recurrence; it is an attractive option and should be considered in patients with lesions recurring after stripping as well as in those whose follow‐up presents a problem. © 1996 John Wiley & Sons, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here